Personalis (PSNL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PSNL Personalis

Watchlist

5.050
-0.140-2.70%

Close Oct 31 16:00 ET

5.290
+0.240+4.75%

Post 20:02 ET

332.97MMarket Cap-3079P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: Personalis to Report Financial Results Post-market on November 06
Moomoo News21:00 ET
Personalis to Announce Third Quarter 2024 Financial Results
BusinesswireOct 23 16:01 ET
Hedge Funds Pile Into Healthcare Stocks Amid Dip, Goldman Sachs Says
Seeking AlphaOct 6 14:47 ET
Lake Street Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsSep 20 09:33 ET · Ratings
Lake Street Keeps Their Buy Rating on Personalis (PSNL)
TipRanksSep 20 08:45 ET · Ratings
Express News | Personalis - Cumulative Value of Task Orders Received by Co Under Its Contracts With Va Mvp Has Increased to About $210.7 Mln
ReutersSep 19 17:31 ET

Comments

Stock_Drift

Aug 18 17:37

8/19/24 🦍’s 👀’s on 🚨🚨🚨🚨

$Virax Biolabs (VRAX.US)$ $Airship AI (AISP.US)$ $Personalis (PSNL.US)$ $Emergent BioSolutions (EBS.US)$ $Chimerix (CMRX.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

Stock Region

Aug 18 17:13

Medical Company Announces Expanded Collaboration With Technology Firm

Expanding Horizons in Cancer Management: The Collaboration of Personalis, Inc. and Tempus AI, Inc..
In a world where technological advancements continually reshape the landscape of healthcare, collaboration among industry leaders plays a pivotal role in accelerating innovation. A testament to this is the expanded collaboration between Personalis, Inc., a renowned leader in cancer genomics, and Tempus AI, Inc., a technology-driv...